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The  interaction of T  (thymus-derived) cells and  B  (bone  marrow-derived) cells 
which results in an optimal humoral immune response has been well documented (1-3); 
however, the actual mechanisms involved in this cooperative process have not been 
clearly delineated. Numerous hypotheses for T- and B-cell interaction have been pro- 
posed (4, 5). Some reports suggest that T  cells carry antigen to B cells, thus increasing 
antigen concentration and stimulating B cells (6) ; in addition, the T  cells may further 
stimulate B cells through surface interaction (4). More recent reports suggest that T 
cells release both nonspecific (4, 7-9) and antigen-specific soluble factors (9) which may 
or may not be complexed with antigen; the antigen-specific T-cell factor may act as 
the first "signal" (10) and other T-cell products may act as the second signal for ini- 
tiation of B-cell synthesis of antibody. In the case of T-cell factors, direct T- and B-cell 
interaction (cell "bridging" with antigen) would not be necessary. However, the posited 
mechanisms involved in T- and B-cell interaction may all function in varying degrees, 
depending on the characteristics of the antigen and the responding organisms. 
In order to function in any direct cooperation with B cells, T  cells must be capable 
of binding antigen. T  cells have the ability to directly bind antigens (11-13). One such 
antigen which T cells have been shown to bind is 2,4-dinitrophenyl-human IgG (DNP- 
HGG)  I  (14);  a  binding specific, in part, for the DNP  haptenic determinant. Other 
workers have also recently reported that T  ceils show specificity for haptenic deter- 
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minants (15,  16). The direct binding of DNP-HGG by CBA/J thymus cells can be 
inhibited with the affinity labeling compound, meta-nitrobenzenediazonium  fluoborate 
(m-NBDF), indicating  that m-NBDF probably binds to an antigen-specific  receptor of 
the T  cell (14). 
Since m-NBDF will covalently bind to  DNP  receptor  active sites,  it  was 
decided to investigate its immunogenicity  when coupled to syngeneic lymphoid 
cells. If an immune response developed, the only immunogen would be  either 
coupled to or released from a  specific type of lymphoid cell, thus  making the 
study  of  the  mechanisms involved in  T-B-cell  cooperation  somewhat  more 
straightforward. 
In this investigation, the abilities of various combinations of  lymphoid cells 
labeled with m-NBDF to produce an in vivo immune response to  DNP  were 
studied.  The  transfer of  immunogenicity (into  the  irradiated  recipients)  by 
means of m-NBDF was shown to take place only if the T-cell or B-cell receptor 
was free to react with the m-NBDF on corresponding B or T  cells, respectively. 
It was  further shown that T  cells are  active participants in the  response  in 
that they do not just act as passive carriers of the haptenic determinant. 
Materials and Methods 
Animals.--The thymus, spleen (S), bone marrow (Bm), and mouse red blood cells (MRBC) 
were  obtained  from  normal  6-8-wk  old  female CBA/J  mice  (Jackson Laboratories,  Bar 
Harbor, Maine). Mice were maintained  on Purina chow pellets (Ralston Purina Co., St. Louis, 
Mo.) and water with neomycin (1 mg/ml) ad libitum. 
Preparation of Cells.--Spleens,  thymuses, and tibias were removed from the mice after 
exsanguination; single cell suspensions were prepared  as previously described (17). Briefly, 
thymuses or spleens were grated  on stainless steel screens and then filtered  through  nylon 
netting. Bm cells were obtained by forcing media through the tibia marrows. A balanced salt 
solution (BSS) was used for the isolation of all cells, and all operations were done at 4°C. 
MRBC were obtained from the CBA/J mouse blood which was collected in a heparin-saline 
solution and washed with BSS. 
lrradiation.--All  mice to be irradiated were exposed to 900 R of 3,-radiation from a 137Cs 
irradiator at a dose rate of 123 fads/rain. The irradiated, syngeneic recipient mice received cells 
within 3 h of irradiation.  A dose of 3,000 R was used to irradiate  cell suspensions; the cells 
were kept at 4°C during irradiation. Cell viability was not significantly changed when deter- 
mined immediately after irradiation by trypan blue exclusion. 
Antisera.--AKR anti-0 serum was prepared by the method of Reif and Allen (18), except 
that CE/J thymus cells were used; AKR anti-(CE/J) 0 eliminates the possibility of any anti- 
bodies to the Ly determinants when used on CBA/J thymus cells. Cytotoxicity tests  showed 
that the antiserum was specific for T lymphocytes. The anti-0-treated  S cells were obtained 
as previously described (14). The amplifying serum used for the hemolytic plaque assay was 
goat antimouse IgG serum. 
Proteim.--Bovine serum albumin (BSA) was obtained from Armour & Co., Chicago, Ill., 
and human IgG (HGG) was obtained as Cohn fraction II through the courtesy of the Ameri- 
can Red Cross National Fractionation Center, and was further purified by DEAE-cellulose 
column  chromatography.  DNP38-BSA and  DNP62-HGG were prepared  by following the 
method described by Eisen (19). Murine IgA myeloma proteins (MP) MOPC 315 (anti-DNP) 
and S121 were isolated from the serum of BALB/cSt  female mice in which the MOPC 315 
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were labeled with x25I (Cambridge Nuclear Co., Cambridge, Mass.)  by a chloramine T  pro- 
cedure (20) in small volumes (21); the specific activities were 32,  15, and 24 #Ci//~g, respec- 
tively. 
A ~nity Labeling of the Cell Preparations.--The  DNP affinity labeling compound m-NBDF 
was prepared according to the method of Traylor and Singer (22). The m-NBDF concentra- 
tion used for labeling was 5 X  10  -5 M in BSS. Cell concentrations of lymphoid cell prepara- 
tions and MRBC were 2 X  l0  T and 5 X  l0  T, respectively; the labeling was performed for 2 h 
at 4°C. Lymphoid cell viability as determined by trypan blue exclusion was >75% before and 
after labeling. 
Hemolytic Plaque Assay.--The number of antibody-producing cells was enumerated by a 
modification (23) of the Jerne plaque technique (24). Indirect plaques were determined using 
amplifying serum, goat antimouse IgG. BSA and DNP-BSA were covalentiy coupled to goat 
red blood cells (GRBC) and used as indicator cells. 
In Vi, o Measurement of the Immune Response to DNP.--Various doses of normal or treated 
cell types were injected intravenously into  irradiated  syngeneic mice and  the  number  of 
plaque-forming cells (PFC)/106 S cells was measured at the time of maximum response (day 
9)  as determined by previous kinetic experiments. No additional immunogen other than la- 
beled lymphoid ceils was administered. The number of indirect plaques specific to DNP was 
calculated by subtracting the number of plaques to BSA-GRBC from the number of plaques 
to DNP-BSA-GRBC. Only indirect plaques were determined because the number of direct 
plaques was insignificant in comparison to the number of indirect plaques. The results were 
considered significant when 0.05  >  P  >  0.01 by Student's t test. 
Migration of Irradiated A finity Labeled T Cdls.--The m-NBDF-labeled T cells were labeled 
with 51Cr by the method described by Sanderson (25). In addition, an aliquot was irradiated 
with 3,000 R. 20 X  106 of either irradiated or nonirradiated T cells were injected intravenously 
into the 900 R irradiated syngeneic mice, and migration was monitored by counting the radio- 
activity in various tissues of the recipient mice at 4, 24, and 48 h. 
Anti-DNP Antibody  Binding  to m-NBDF-Labeled  T  Cells.--125I-labeled MOPC  315  and 
S121 MP were incubated with 5 X  l0  s normal thymus cells or m-NBDF-labeled thymus cells 
in 0.1 ml of BSS for 30 rain at 4°C. The cells were then suspended in 1 ml of BSS and centri- 
fuged through 6 ml of 100% fetal calf serum (FCS). The cell pellet was resuspended in 1 ml of 
BSS and transferred to a smaller tube for counting. The cells were incubated with 20, 40, 80, 
or 200 ng of [I~5I]MOPC 315 or [125118121 MP. 
Antigen Binding  and In Vitro Incubation of S  Cells.--An autoradiographic assay was em- 
ployed to study  S-cell binding of DNP-HGG and inhibition of this binding with m-NBDF 
(14). In vitro recovery from this inhibition was studied by incubating the S-cell preparations 
in vitro in accordance with the method of Mishell and Dutton (26). Mter 3, 8, 24, and 48 h of 
incubation,  normal S-(NS) cell and m-NBDF-labeled S-cell cultures were removed, washed 
once in minimal essential media containing 5% FCS and 0.1% sodium azide, and examined 
for DNP-HGG binding by means of an autoradiographic assay. 
RESULTS 
In Vivo Synergism of Thymus and Bm Cells.--As shown in Table I, there was 
a  slight  but  not  significant  increase  in  the  number  of  PFC  to  DNP  when 
m-NBDF-labeled  T  (T*)  cells  and  normal  Bm  (NBm)  cells were  injected  as 
compared  to when normal T  (NT)  cells and NBm  cells were injected into  the 
irradiated,  syngeneic  recipients  given  no  additional  immunogen.  This  slight 
increase in the number of PFC to DNP  did not occur after injection of T* cells 
with m-NBDF-labeled  Bm  (Bin*)  cells. The Bm* cells plus NT  cells did not 
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TABLE  1 
In Vivo Synergism of CBA /J Mouse Thymus and Bone Marrow Cells in the Immune Response 
to the DNP Group 
Treatment*  Indirect PFC/IO  s spleen cells ±  SE~ 
NT +  NBm  48  -4- 6 
T*+NBm  67  q-  8 
T* +  Bm*  39  -4- 5 
NT+Bm*  46  q-  7 
NBm  20  -4- 2 
T*  12  ±  3 
* Cells injected into syngeneic CBA/J recipients irradiated  with 900 R. NBm, 3  X  107 
normal  bone marrow cells; NT,  10 X  107 normal  thymus cells; Bm*, 3 X  107 m-NBDF- 
labeled bone marrow cells; and T*, 10 X 107 m-NBDF-labeled thymus cells. 
:~ The results represent the averages from three or more separate experiments. 
selves  gave  background  levels  of  PFC  to  DNP  similar  to  those  previously 
reported for NS cells (27). The PFCs observed when T  cells alone are injected 
are probably due to DNP specific B  cells of the recipient which have escaped 
the effects of irradiation. 
Ability of m-NBDF-Labeled Lymphoid Cells to Provide Stimulation for an In 
Vivo Immune Response to DNP.--Since there was a  slight increase in the im- 
mune  response  to DNP  when  T*  cells  and  NBm  cells  were injected  into  ir- 
radiated,  syngeneic  recipients,  it  was  assumed  that  the  response  might  be 
significantly enhanced if S cells were used intead of NBm cells. This assumption 
was based on the fact that spleen B  cells seem to have a greater degree of im- 
munological maturity than Bm cells  (28). T* cells injected with NS cells into 
recipients  with  no  additional  immunogen  produced  a  significant  threefold 
increase in the number of PFC to DNP  as compared to the number produced 
with NS cells alone (Table II).  Twice as many T* cells (2  X  l0  s) resulted in a 
significant four- to fivefold increase.  In order to determine  whether T  cells in 
the NS population had any effect on enhancement,  NS cells were treated with 
anti-0 serum and complement (C'). As shown, there was no significant change 
in number of PFC. When T* cells were injected in combination with m-NBDF- 
labeled S  (S*) cells, there was no enhancement of the response; the number of 
PFC did not significantly differ from that obtained when  S* cells  alone were 
injected. This would seem to indicate that T* cells and S* cells do not interact. 
NT cells injected  with NS  cells gave a  response even lower than  the NS  cell 
control. NT cells with S* cells gave a  significant enhancement of the immune 
response  to  DNP  indicating  that  there  must be a  direct  T-B-cell  contact  in 
this system. 
Irradiation of m-NBDF-Labeled T  (T*) Cells.--The ability of the T* cells to 
produce an elevated in vivo immune response to DNP when injected with NS 
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TABLE II 
In Vivo Ability of m-NBDF-Labded CBA/J Mouse Thymus Cells to Initiate the PFC Response 
to the DNP Group 
Treatment*  Indirect PFC/10  6 S cells -4- SEt 
NS  55  -4- 5 
T* -[- NS  137  -4- 22 
2  X  T* -b NS  227  -4- 37 
T*  +  NS (anti-0 -b C')  144  q-  19 
T* q- S*  87  -4-  15 
S*  70  4-  4 
NTq-NS  37  ±  15 
NT +  S*  152  -4- 33 
* Cells injected  into  syngeneic CBA/J recipients  irradiated  with 900 R.  NS,  3  X  107 
NS cells; S*, 3 X  107 m-NBDF-labeled S ceils; T*, 10 X  107 m-NBDF-labeled thymus cells; 
and NT, 10 X  107 normal thymus cells. 
:~ The results represent the averages from three or more separate experiments. 
involvement of T  cells, such as the liberation of B-cell-stimulating products, or 
of a passive role, such as carrier of the affinity labeling haptenic determinant to 
the B  cells.  In an attempt to determine  the function of T  cells,  they were ir- 
radiated with 3,000 R; a  dose that would ordinarily destroy the normal func- 
tioning of all lymphoid cells since their mean lethal dose is approximately 520 R 
(29). The irradiation was performed either before or after affinity labeling of the 
T  cells. As shown in Table III, there was no difference in number of PFC to 
DNP  regardless  of whether irradiation was given before or after labeling,  but 
in both cases the immune response was inhibited by approximately 50%. 
Migration of Irradiated Cdls.--Since the immune response was reduced 50 % 
after irradiation,  it appears that some T  cells may perform an active function 
in production of an immune response to DNP. There may be various subpopula- 
tions within  the thymus cell preparation  that function differently. The reduc- 
tion,  however,  could be caused by a  difference in the migration  of irradiated 
cells,  i.e.,  fewer of these  cells  may home to the  spleen  and  therefore  cause  a 
reduction in the number of PFC/106 S cells. In order to determine if there was a 
difference  in  the  migratory pattern,  the  cell  preparations  were  labeled  with 
51Cr and injected intravenously into irradiated recipients. There was no reduc- 
tion in number of irradiated T* cells which homed to the spleen; in fact, by 48 
h  there were slightly more irradiated  T* cells present in the spleen  than non- 
irradiated T* cells (Table IV). Thus, spleen homing of T  cells is apparently not 
affected by irradiation, but the ability of T  cells to leave the spleen after reach- 
ing it may be affected by irradiation  (30). 
Cell  Type Capable  of Transferring the Immune Response to DNP.--As shown 
in Table II, T*  cells in combination with NS cells will produce  an  enhanced 
immune response to DNP.  S*  cells  alone  are not capable  of producing  a  sig- 
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TABLE III 
Effect of Irradiation on the In Vivo Helper Ability of the m-NBDF-Labded Thymus Cells 
Treatment*  Indirect PFC/IO  6 S cells q- SEt 
NS  37  -4- 6 
T*+NS  185  ±  49 
3,000 R-T* +  NS  86  +  11 
T*-3,000 R +  NS  99  q-  16 
* Cells injected into syngeneic CBA/J recipients irradiated with 900 R. NS, 3 ×  107 NS 
cells; T*, 20 X  107 m-NBDF-labeled thymus cells; 3,000 R-T*, 20  X  107 normal thymus 
cells irradiated  with 3,000 R  and then  m-NBDF-labeled cells; T*-3,000 R, 20  X  l0  T m- 
NBDF-labeled thymus cells irradiated with 3,000 R. 
Each result represents the average from seven or more individual  recipients. 
TABLE  IV 
Ratio of the In Vivo Distribution of the m-NBDF-Labded T (T*) Cells to the 3,000 R Irradiated 
T* Cells 
Time after cell injection 
~XCr sample 
4 h  24 h  48 h 
Blood  0.64*  2.69  0.95 
Lung  1.88  2.26  1.50 
Thymus  1.00  1.00  0.92 
Kidney  1.38  1.25  1.29 
Spleen  1.04  0.83  0.79 
Liver  0.97  1.05  1.07 
* Represents  (percent  recovery  of  51Cr-nonirradiated T*  cells)/(percent  recovery  of 
51Cr-irradiated T* cells); percent  recovery equals cpm of 51Cr T* cells per  tissue/cpm  of 
51Cr T* ceils injected into 900 R irradiated,  syngeneic CBA/J recipients. The ratios were 
obtained from three individual mice in each group. 
other  than T  cells was  capable of  transfering the immune response to  DNP 
(Table V), CBA/J  MRBC and Bm cells were affinity labeled and transferred 
along with NS. MRBC* or Bm* cells plus NS did not significantly  increase the 
number of PFC above that obtained with NS cells alone, whereas T* cells plus 
NS cells in this experiment gave a fourfold increase in number of PFC. 
Anti-DNP Antibody Binding  to m-NBDF-Labeled  T  Cells.--If T* cells can 
specifically stimulate DNP-specific B  cells, then B-cell antigen-binding  recep- 
tors must be able to recognize the haptenic determinant on the T  cells. This 
possibility was  investigated by  attempting to  determine whether  anti-DNP 
antibody would preferentially bind to T* cells. It was assumed that the active 
site of  an antibody molecule is similar to  that  of  the  cell receptor.  MP  315 
which has anti-DNP activity (31)  and, as a  control, the MP S121  were used 
so  that cytophilic antibody properties would not be involved since it has re- 
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(unpublished  results).  At  all  concentrations  tested,  T*  cells  always  bound 
approximately twice as much 315  MP as the NT cells; there was no difference 
in the amount of S121 MP bound by T* and NT cells. 
The ratio of the amount of 315  or S121 MP which was bound to T* cells as 
compared to NT cells is expressed as  an average for all concentrations  from 
three separate experiments ±  SE. T*/NT for 315  MP was 2.14  ±  0.10  and 
T*/NT for S121 MP was 1.20 +  0.09; these results were significantly different 
(P  <  0.001)  by Student's t  test.  Thus,  it  seems apparent  that  the haptenic 
determinant  on T* cells  can be recognized by DNP-specific antigen-binding 
sites of B-cell receptors. 
In  Vitro  Turnover  of DNP-HGG S-Cell  Receptor.--As  shown in  Fig.  1,  m- 
NBDF inhibition of DNP-HGG binding by S  cells is gradually  lost  after  in 
vitro incubation of the S cells.  Recovery is faster from an initially lower con- 
centration  of m-NBDF  (5  X  10  -~ M), but even with 5  X  10  -5 M  m-NBDF 
TABLE  V 
In  Vivo Ability  of m-NBDF-Labded  Bm,  MRBC,  and  Thymus  Cells  to  Initiate  the  PFC 
Response to the DNP Group 
Treatment*  Indirect PFC/106 spleen cells 4- SE* 
NS  55  ±  5 
MRBC* +  NS  62  4-  8 
Bm*+NS  69  4-  9 
T*+NS  204  ±  29 
* Cells injected into syngeneic CBA/J recipients irradiated with 900 R. NS, 3  X  107 NS 
cells; MRBC*,  40  X  l0  T m-NBDF-labeled MRBC;  Bin*,  5  X  107  m-NBDF-labeled  Bm 
cells; and T*, 20 :K 107 m-NBDF-labeled thymus cells. 
Each result represents the average of nine or more individual recipients. 
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FIG.  1.  In vitro recovery of mouse S cell binding of I)NP-HGG after inhibition with m- 
NBDF.  The ordinate represents the arithmetic  mean from three separate experiments ex- 
pressed as percent inhibition of DNP-HGG binding calculated from the following: 1  --  (% 
m-NBDF-labeled S-cell binding of DNP-HGG/% unlabeled S-cell binding of DNP-HGG)  X 
100. The labeled and unlabeled S cells at each in vitro time were harvested from three separate 
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the inhibitory effect is completely gone by 48 h. The fact that in vitro recovery 
is not linear indicates that the cells are not in synchrony and/or not all cells 
are inhibited equally. The results also indicate that S cell receptors for DNP- 
HGG are released  and  replaced in  48  h  or  less;  this  is  especially significant 
when considering the fact that T* cells plus NS cells gave an enhanced response 
to DNP, but T* cells plus S* cells did not significantly enhance the immune 
response to DNP. 
DISCUSSION 
The experiments reported here suggest that stimulation of B cells to produce 
antibodies to DNP may, in part, result from direct contact between T  and B 
cells.  The injection of either affinity labeled T  (T*) cells and NS cells or NT 
cells and affinity labeled S  (S*) cells into irradiated recipients that were given 
no additional immunogen resulted in an immune response to DNP; however, 
when T* and S* cells were injected,  there was only a slight increase over the 
normal number of background PFC to DNP  (27).  Since there is an enhanced 
response to DNP with T* and NS cells or NT and S* cells,  the simplest mech- 
anism of interaction to account for this response would be cell to cell contact, 
although soluble factors probably also play a role (7-9). In the case of T* and 
NS cells eliciting an increased response, it is possible that an antigen-specific 
factor is liberated from the T* cells which in turn directly or indirectly stimu- 
lates the B  cells; if direct cellular interaction is not involved, though,  the re- 
sponse obtained by NT and S* cells would require that antigen be transferred 
from the B  cells to T  cells and back again through some intermediate system. 
The  possible biological  significance  of such  a  complex system is  difficult  to 
comprehend when  the  simple mechanism of T- and B-cell interaction  would 
suffice to explain the increased response. Interestingly, B* cells apparently can 
carry antigen to T  cells and so initiate T-cell antigenic stimulation; a situation 
which is the reverse of what is usually proposed (6). The results of Rajewsky 
et al.  (32)  support the concept that efficient in vivo antibody induction relies 
on cell to cell interaction mediated by antigen bridging. The fact that T* and 
S* cells do not collaborate also favors the possibility of cell to cell contact, be- 
cause when receptors are blocked there can be no bridging of cells and therefore 
no initiation of events for synthesis of antibodies to DNP. The absence of cell to 
cell interactions when T* and B* cell receptors are concomitantly blocked could 
similarly result when a great excess of antigen blocks receptors or passive anti- 
bodies block free determinants of an antigen already bound to one cell type. A 
previous study (14) has shown that m-NBDF specifically inhibits the binding of 
DNP protein  conjugates by murine thymus and  S  cells,  thus  it is not unex- 
pected that when m-NBDF is bound to T- and B-cell receptors it can block cell 
cooperation. Plotz  (33)  and Segal et al.  (34)  have used other affinity labeling 
compounds on lymphoid cells to inhibit a specific immune response to DNP or 
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bound m-NBD  determinant on correspondingly labeled B  or T  cells,  the m- 
NBD moiety can be immunogenic, de Weck (35)  has shown that hapten con- 
jugated to lymphoid cells is important to elicit a response, e.g., stimulation of 
lymphocytes by penicillin added to culture medium requires covalent binding 
of the pencillin molecule and that conjugation of penicillin to lymphoid ceils is 
more stimulating for antigen-sensitive cells than conjugation to soluble proteins 
or to erythrocytes. 
T and B cells apparently can "bridge" through the covalently bound haptenic 
determinant (the m-NBD residue) and only interact if one cell type is labeled. 
The capacity to bridge is evidenced by the ability of an anti-DNP antibody, 
MOPC 315, to specifically bind to affinity labeled T  cells. This indicates that 
DNP-specific receptors on B  cells could also bind to the m-NBD moiety on T 
cells  assuming  that  the  receptor and  antibody  active sites  are  similar.  The 
bridging of T* and B or T  and B* cells probably results from a specific receptor 
binding a m-NBD residue which has been bound to a membrane protein on the 
collaborating cell. However, an alternative possibility for bridging could be that 
the m-NBD moiety can be bound by the active site of a receptor and still be 
recognized by another receptor. Recognition, then, must be via different speci- 
ficities of the m-NBD molecule. It has been shown that there is a heterogeneous 
population of anti-DNP antibodies (36), and receptors are probably also heter- 
ogeneous which may allow for mutual recognition of the m-NBD residue by two 
individual receptors. Even if the initial bridging is not due to specific receptors 
on T  and B cells, T* cells still seem to preferentially stimulate B cells because 
T* cells can initiate a response to DNP; however, MRBC* and Bin* cells are 
incapable of eliciting a response with NS cells, even though a portion of the Bm 
cells is capable of being stimulated to synthesize antibodies. Therefore, the T* 
cells must contribute more to B-cell stimulation than just hapten presentation. 
After antigen bridging, T- and B-cell membranes may be attracted for further 
collaboration. The stimulation of the B cell through its receptors could then be 
due to a cross-linking of receptors by the T-cell membrane which provides the 
two postulated "signals" for antibody production (10). Direct cell contact would 
be advantageous even when considering T-cell factors (7-9); these factors may 
have a limited range, and cell contact might lower any diluting effects resulting 
from the cells not being in close contact. The in vitro system described by Bas- 
ten and Feldmann (9) involving T- and B-cell separation with a membrane in- 
dicates that direct cell contact is not necessary; however, if the T  and B  cells 
were not separat'ed by a membrane, the response might be further enhanced. 
The above discussion does not include the role of the macrophage. Many studies 
indicate that macrophages play an important intermediate role in the initiation 
of the humoral immune response (4,  9). Macrophages bridging T  and B  cells 
could  easily fit into  the  mechanisms  described.  The membrane  interactions 
would simply manifest themselves on or through the macrophage membrane. 
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recipient may be critical for the interaction of T  and B cells,  because when the 
T* and S* cells were injected there was no significant response to DNP, for the 
B-cell receptors are not free to react until 24-48 h  after labeling. It is possible 
that when T* and S* cells are injected the response is delayed until the B-cell 
receptors are free to react with T* cells or their products, or that by the time 
B-ceU receptors are free to react, the T* cells may have already shed their re- 
ceptors, and cellular interaction may not be optimal. The in vitro receptor turn- 
over was investigated by observing the recovery of DNP-HGG binding by the 
S* cells. The turnover time of surface immunoglobulins or receptors  (37,  38) 
has been reported by others as being 6 h  to 2 wk. The reason for this variation 
is not known.  In the present study,  the turnover time of the receptors which 
bind DNP-HGG was 24-48 h. 
The helper function of T* cells observed in this investigation was not limited 
to  ability to concentrate antigen  and present it  to B  cells.  In fact,  although 
m-NBDF will selectively bind to the DNP-specific receptors on the lymphoid 
cells, it could also bind to other membrane proteins. In order to find out if the 
cells were only carriers of antigen and played no other functional role, T* cells 
were irradiated with 3,000 R, a dose which usually prevents DNA synthesis and 
eventually causes cell death  (29).  After irradiation  of T* cells  and  injection 
along with NS cells into the recipients, the response to DNP was reduced but 
not completely ablated. Reduction of the response indicates that the T  cells or 
at least a fraction of them were performing an active function other than that of 
carrier. Active involvement of T  cells is confirmed by the result obtained when 
NT and S* cells were injected;  there was an increase in number of anti-DNP 
PFC,  and in this case, the T  cells are not carriers but are actively involved in 
some other way. Miller et al.  (39)  using tolerant T  cells coupled with antigen 
has given further evidence that T  cells are more than just a passive carrier of 
the immunogen. A different in vivo migration of T* cells due to irradiation was 
experimentally ruled  out as a possible cause for reduction  in the response to 
DNP. The fact that irradiation apparently does not affect cell migration is in 
agreement with the result of Anderson et al.  (30), who found no change in the 
S-cell homing of irradiated T  cells.  The 50 % reduction in the number of PFC 
to DNP which  results from irradiation  of T* cells could be accounted for by 
there being:  (a)  subpopulations of active thymus cells varying in their sensi- 
tivity to irradiation;  (b)  thymus cells having two or more functions and these 
functions varying in their sensitivity to irradiation; or (c) a combination of the 
above, i.e.,  different  types of T  cells performing different functions  and  also 
varying in their sensitivity to irradiation. 
The  murine  thymus  has  been  shown  to  contain  cells  capable  of binding 
DNP-HGG (14); some of these cells may have been naturally "activated" to 
DNP. This is not inconceivable since there are PFC cells in normal mice which 
produce antibodies to DNP (27). Thus, there may be T  cells in various states 
of differentiation  which  have specificity for DNP,  and  these  cells may have 
different sensitivities to the various effects of irradiation. T-cell factors may also DAVID  A.  LAWRENCE  AND  WILLIAM  O.  WEIGLE  953 
be  responsible  for maintenance  of  a  lowered immune  response because  the 
"allogenic" or nonspecific factor can still be released from irradiated T  cells 
and stimulate B  cells (8).  Subpopulations of T  cells do reside in the thymus 
since, for example, there are cortisone-resistant and -sensitive populations (40). 
Subpopulations of T  cells have been described and are referred to as T1 and T2 
cells (41). These subpopulations of T  cells have different functional properties 
and different radiosensitivities (42). Feldmann and Basten (43) have shown that 
the helper effect of NT cells and primed T  cells is reduced with mitomycin C, 
but activated T  cells are not affected. These results with mitomycin C may be 
similar to irradiation effects since both are inhibitors of DNA synthesis and cell 
division. Other studies have shown that the effects of irradiation can inhibit 
completely or only slightly inhibit the helper activity of T  cells  (30,  44-46). 
Whether or not T  cells are radiosensitive or radioresistant is in itself contro- 
versial. Their radiosensitivity may be determined by their immune status, i.e., 
whether they have been or are being stimulated by antigen and/or are differ- 
entiating. The reduction in the response to DNP due to irradiation of T  cells 
may result from loss of direct T- and B-cell contact which again points out the 
possible advantage of membrane interactions. Radiation effects are known to 
cause membrane changes which result in cell leakage (47, 48). Membrane de- 
formities may interfere with T- and B-cell interaction and lower, if not ablate, 
the efficiency of the interaction. 
SUMMARY 
The  ability  of meta-nitrobenzenediazonium fluoborate  (m-NBDF)-labeled 
thymus and spleen (S) cells to transfer immunity to 2,4-dinitrophenyl (DNP) 
into irradiated syngeneic recipients was investigated. There was  a significant 
increase  in  the  number  of  anti-DNP  plaque-forming  ceils  (PFC)  when  m- 
NBDF-labeled thymus cells and normal spleen cells,  or normal thymus cells 
and m-NBDF-labeled spleen cells were transferred, but not when both thymus- 
and S-cell populations were labeled and injected together into irradiated re- 
cipients. The ability of these cell populations to cooperate and enhance the in 
vivo immune response to DNP is discussed. The T  cells seem to be actively 
involved in the development of this response; they participate beyond the mere 
role of carrying and presenting antigen to the B cells.  It is suggested that cell 
to cell contact between T  and B cells may be an important factor in the elicita- 
tion of an immune response. In addition, the cellular interaction is affected by 
irradiating the thymus cell preparation and the initiating interaction required 
for antibody  synthesis  probably occurs within  48  h  after injecting  the  cell 
populations into the syngeneic irradiated recipients. 
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